Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|August 15, 2014
Urinary sodium and potassium excretion, mortality, and cardiovascular eventsMartin O'Donnell, Andrew Mente, Sumathy Rangarajan, et al.
Annals of Internal Medicine|November 7, 2022
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations : A Randomized, Multicenter TrialJeff S Healey, Andrew D Krahn, Jamil Bashir, et al.
The New England Journal of Medicine|November 18, 2024
Colchicine in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Shun Fu Lee, et al.
Heart (British Cardiac Society)|September 4, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trialMarc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi, et al.
Heart (British Cardiac Society)|October 26, 2017
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the worldPhilip Joseph, Salim Yusuf, Shun Fu Lee, et al.
The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.
Lancet (London, England)|August 16, 2025
Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trialMichael Walsh, David Collister, Martin Gallagher, et al.
JAMA|October 12, 2023
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical TrialDeborah M Siegal, Emilie P Belley-Côté, Shun Fu Lee, et al.
The New England Journal of Medicine|November 18, 2024
Routine Spironolactone in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Bertram Pitt, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Pageof 8